Komori
Fuso Pharmaceutical Industries (4538) · InitiativeRestated

Enhancing Earnings Power by Streamlining Administrative Organizations and Improving Operational Efficiency

First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2019.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20192016: 120162017: 120172018: 120182019: 12019
Same theme, other companies
Organizational Consolidation and Management Structure StreamliningA theme 19 companies write about · 0 as a headwind · 19 as a tailwind

The whole theme swung hardest in 2020: 3 of 10 companies on the "Worse" side.

7 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuso Pharmaceutical Industries yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enhancing Earnings Power by Streamlining Administrative Organizations and Improving Operational Efficiency | Fuso Pharmaceutical Industries,Ltd. (4538) | Komori